Global Metabolomics Market by Detection and Separation Techniques, and Applications, Growth Trends and Forecast to 2021, by iHealthcareAnalyst, Inc.
Metabolomics Market by Detection and Separation Techniques, and Applications (Biomarker Discovery, Clinical Toxicology, Drug Assessment, and Nutrigenomics) and Forecast 2017-2021
Maryland Heights, MO, April 15, 2017 --(PR.com)-- Metabolomics is the scientific study of chemical processes involving metabolites, whereas metabolome represents the collection of all metabolites in a biological cell, tissue, organ or organism, which are the end products of cellular processes. mRNA gene expression data and proteomic analyses reveal the set of gene products being produced in the cell, data that represents one aspect of cellular function including systems biology and functional genomics that integrates proteomic, transcriptomic, and metabolomic information to provide a better understanding of cellular biology. Metabolomics is an advanced, specialized form of analytical biochemistry that involves the study of chemical processes involving metabolites. Metabolomics enables simultaneous identification and analysis of multiple metabolites in cells, tissues and body fluids. The research funding for metabolomics has increased over the years in the major areas of research includes characterization and identification of novel biomarkers, therapeutic targets, and disease signatures in the area of cancer metabolomics.
Browse Metabolomics Market by Detection and Separation Techniques, and Applications (Biomarker Discovery, Clinical Toxicology, Drug Assessment, and Nutrigenomics) and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/metabolomics-market/
The global metabolomics market report estimates the market size (Revenue USD million - 2014 to 2021) and key market segments based on detection and separation techniques used, its applications (biomarker discovery, clinical toxicology, drug assessment, and nutrigenomics), and forecasts growth trends (CAGR% - 2017 to 2021). The global metabolomics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global metabolomics market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major players operating in the global metabolomics market and included in this report are Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Shimadzu Corporation, and Waters Corporation.
1. Technique
1.1. Detection Techniques
1.2. Separation Techniques
2. Application
2.1. Biomarker Discovery
2.2. Clinical Toxicology
2.3. Drug Assessment
2.4. Nutrigenomics
3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World
4. Company Profiles
4.1. Agilent Technologies Inc.
4.2. Biocrates Life Sciences AG
4.3. Bio-Rad Laboratories, Inc.
4.4. Bruker Corporation
4.5. Human Metabolome Technologies Inc.
4.6. LECO Corporation
4.7. Metabolon Inc.
4.8. Shimadzu Corporation
4.9. ThermoFisher Scientific Inc.
4.10. Waters Corporation
To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/metabolomics-market/
About Us
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com
Browse Metabolomics Market by Detection and Separation Techniques, and Applications (Biomarker Discovery, Clinical Toxicology, Drug Assessment, and Nutrigenomics) and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/metabolomics-market/
The global metabolomics market report estimates the market size (Revenue USD million - 2014 to 2021) and key market segments based on detection and separation techniques used, its applications (biomarker discovery, clinical toxicology, drug assessment, and nutrigenomics), and forecasts growth trends (CAGR% - 2017 to 2021). The global metabolomics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global metabolomics market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major players operating in the global metabolomics market and included in this report are Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Shimadzu Corporation, and Waters Corporation.
1. Technique
1.1. Detection Techniques
1.2. Separation Techniques
2. Application
2.1. Biomarker Discovery
2.2. Clinical Toxicology
2.3. Drug Assessment
2.4. Nutrigenomics
3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World
4. Company Profiles
4.1. Agilent Technologies Inc.
4.2. Biocrates Life Sciences AG
4.3. Bio-Rad Laboratories, Inc.
4.4. Bruker Corporation
4.5. Human Metabolome Technologies Inc.
4.6. LECO Corporation
4.7. Metabolon Inc.
4.8. Shimadzu Corporation
4.9. ThermoFisher Scientific Inc.
4.10. Waters Corporation
To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/metabolomics-market/
About Us
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 500-7508
https://www.ihealthcareanalyst.com/
Ana Aitawa
(314) 500-7508
https://www.ihealthcareanalyst.com/
Contact
Categories